First Time Loading...

Aurinia Pharmaceuticals Inc
NASDAQ:AUPH

Watchlist Manager
Aurinia Pharmaceuticals Inc Logo
Aurinia Pharmaceuticals Inc
NASDAQ:AUPH
Watchlist
Price: 5.2194 USD 0.96% Market Closed
Updated: May 3, 2024

Aurinia Pharmaceuticals Inc
Cash from Operating Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Aurinia Pharmaceuticals Inc
Cash from Operating Activities Peer Comparison

Comparables:
ZYME
TH
RPTX
FUSN
EDT

Competitive Cash from Operating Activities Analysis
Latest Figures & CAGR of Competitors

Company Cash from Operating Activities CAGR 3Y CAGR 5Y CAGR 10Y
Aurinia Pharmaceuticals Inc
NASDAQ:AUPH
Cash from Operating Activities
-$33.5m
CAGR 3-Years
22%
CAGR 5-Years
8%
CAGR 10-Years
-22%
Zymeworks Inc
NYSE:ZYME
Cash from Operating Activities
-$118.3m
CAGR 3-Years
8%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Theratechnologies Inc
TSX:TH
Cash from Operating Activities
-$4m
CAGR 3-Years
34%
CAGR 5-Years
N/A
CAGR 10-Years
5%
Repare Therapeutics Inc
NASDAQ:RPTX
Cash from Operating Activities
-$127.2m
CAGR 3-Years
-176%
CAGR 5-Years
-59%
CAGR 10-Years
N/A
Fusion Pharmaceuticals Inc
NASDAQ:FUSN
Cash from Operating Activities
-$81.8m
CAGR 3-Years
-40%
CAGR 5-Years
-53%
CAGR 10-Years
N/A
Spectral Medical Inc
TSX:EDT
Cash from Operating Activities
-CA$10.7m
CAGR 3-Years
-222%
CAGR 5-Years
-35%
CAGR 10-Years
-2%

See Also

What is Aurinia Pharmaceuticals Inc's Cash from Operating Activities?
Cash from Operating Activities
-33.5m USD

Based on the financial report for Dec 31, 2023, Aurinia Pharmaceuticals Inc's Cash from Operating Activities amounts to -33.5m USD.

What is Aurinia Pharmaceuticals Inc's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 10Y
-22%

Over the last year, the Cash from Operating Activities growth was 58%. The average annual Cash from Operating Activities growth rates for Aurinia Pharmaceuticals Inc have been 22% over the past three years , 8% over the past five years , and -22% over the past ten years .